[1]
“Role of Hydroxyurea in Reducing Transfusion Requirements in Patients with β-Thalassaemia Major ”, The Insight, vol. 2, no. 02, p. 7, Sep. 2021, Accessed: Oct. 16, 2025. [Online]. Available: https://www.bdjournals.org/insight/article/view/78